TNNT2 and myocardial infarction: Cardiac biomarkers, such as creatine kinase MB (CK-MB) and cardiac troponin T (cTnT), have been proved to be useful in predicting ACS, particularly non-ST segment elevated myocardial infarction (non-STEMI) (11–13).